Idexx Laboratories, Inc. IDXX

NAS: IDXX | ISIN: US45168D1046   26/05/2023
468,94 USD (+2,38%)
(+2,38%)   26/05/2023

21 februari 2023 · IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences · Persbericht

20 februari 2023 · Groundbreaking IDEXX Study Reveals Opportunities to Increase Veterinary Practice Productivity · Persbericht

6 februari 2023 · IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results · Persbericht

26 januari 2023 · IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results · Persbericht

22 december 2022 · IDEXX Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference · Persbericht

1 november 2022 · IDEXX Laboratories Announces Third Quarter Results · Persbericht

11 oktober 2022 · IDEXX Laboratories to Release 2022 Third Quarter Financial Results · Persbericht

2 augustus 2022 · IDEXX Laboratories Announces Second Quarter Results · Persbericht

8 juli 2022 · IDEXX Laboratories to Release 2022 Second Quarter Financial Results · Persbericht

21 juni 2022 · IDEXX Empowers Veterinarians with New Testing Insights that Support Earlier Diagnosis and Intervention for Preventive Care and Critical Cases · Persbericht

18 mei 2022 · IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day · Persbericht

4 mei 2022 · IDEXX Laboratories Announces First Quarter Results · Persbericht

11 april 2022 · IDEXX Laboratories to Release 2022 First Quarter Financial Results · Persbericht

17 februari 2022 · IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences · Persbericht

2 februari 2022 · IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results · Persbericht

13 januari 2022 · PetDx and IDEXX Expand Access to OncoK9, the Cancer Liquid Biopsy Test for Dogs · Persbericht

13 januari 2022 · IDEXX Innovative Diagnostic and Software Solutions Provide Workflow Efficiency and Faster, More Confident Clinical Decisions · Persbericht

13 januari 2022 · IDEXX Enables Improved Cancer Diagnosis and Personalized Care through Expanded Oncology Offering · Persbericht

11 januari 2022 · IDEXX Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results · Persbericht

2 november 2021 · IDEXX Laboratories Announces Third Quarter Results · Persbericht

Mijn selecties